Capital Fund Management S.A. purchased a new position in shares of Vital Farms, Inc. (NASDAQ:VITL - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 42,000 shares of the company's stock, valued at approximately $1,280,000. Capital Fund Management S.A. owned approximately 0.09% of Vital Farms as of its most recent SEC filing.
Several other large investors have also recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd raised its stake in shares of Vital Farms by 20,650.0% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,660 shares of the company's stock worth $51,000 after buying an additional 1,652 shares in the last quarter. US Bancorp DE raised its position in Vital Farms by 36.2% in the first quarter. US Bancorp DE now owns 1,929 shares of the company's stock worth $59,000 after acquiring an additional 513 shares in the last quarter. CWM LLC raised its position in Vital Farms by 43.2% in the first quarter. CWM LLC now owns 2,154 shares of the company's stock worth $66,000 after acquiring an additional 650 shares in the last quarter. Union Bancaire Privee UBP SA purchased a new position in Vital Farms in the first quarter worth $112,000. Finally, Hanson & Doremus Investment Management purchased a new position in Vital Farms in the first quarter worth $130,000. 98.59% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
VITL has been the subject of a number of research analyst reports. Telsey Advisory Group increased their price target on shares of Vital Farms from $46.00 to $50.00 and gave the company an "outperform" rating in a report on Friday, August 8th. BMO Capital Markets reiterated an "outperform" rating on shares of Vital Farms in a report on Friday, August 8th. DA Davidson increased their target price on shares of Vital Farms from $51.00 to $52.00 and gave the company a "buy" rating in a report on Monday, August 11th. Lake Street Capital set a $60.00 target price on shares of Vital Farms and gave the company a "buy" rating in a report on Friday, August 8th. Finally, Mizuho increased their target price on shares of Vital Farms from $45.00 to $53.00 and gave the company an "outperform" rating in a report on Monday, August 11th. Eleven investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and an average target price of $48.20.
Get Our Latest Research Report on VITL
Vital Farms Price Performance
Shares of NASDAQ:VITL traded down $0.29 during midday trading on Friday, hitting $51.09. 952,879 shares of the stock were exchanged, compared to its average volume of 1,232,397. The company has a current ratio of 2.48, a quick ratio of 2.10 and a debt-to-equity ratio of 0.02. The stock has a market cap of $2.28 billion, a P/E ratio of 45.62 and a beta of 0.93. The company has a 50 day moving average price of $41.52 and a 200-day moving average price of $35.88. Vital Farms, Inc. has a twelve month low of $27.91 and a twelve month high of $53.13.
Vital Farms (NASDAQ:VITL - Get Free Report) last announced its earnings results on Thursday, August 7th. The company reported $0.36 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.27 by $0.09. The company had revenue of $184.77 million during the quarter, compared to analysts' expectations of $170.28 million. Vital Farms had a net margin of 7.84% and a return on equity of 18.40%. The firm's quarterly revenue was up 25.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.36 earnings per share. Vital Farms has set its FY 2025 guidance at EPS. On average, research analysts forecast that Vital Farms, Inc. will post 1.11 earnings per share for the current year.
Insider Activity
In related news, CEO Russell Diez-Canseco sold 16,700 shares of Vital Farms stock in a transaction that occurred on Tuesday, August 12th. The stock was sold at an average price of $46.11, for a total transaction of $770,037.00. Following the completion of the transaction, the chief executive officer directly owned 702,476 shares in the company, valued at $32,391,168.36. The trade was a 2.32% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Matthew Ohayer sold 30,000 shares of the business's stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $39.17, for a total value of $1,175,100.00. Following the completion of the transaction, the insider directly owned 6,858,890 shares of the company's stock, valued at approximately $268,662,721.30. This trade represents a 0.44% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 103,901 shares of company stock worth $4,141,052. 21.30% of the stock is owned by corporate insiders.
About Vital Farms
(
Free Report)
Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.
Featured Stories

Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.